These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 35371003)

  • 41. Potential Use of Mesenchymal Multipotent Cells for Hemopoietic Stem Cell Transplantation: Pro and Contra.
    Kiselevskiy M; Vlasenko R; Reshetnikova V; Chikileva I; Shubina I; Osmanov E; Valiev T; Sidorova N; Batmanova N; Stepanyan N; Kirgizov K; Varfolomeeva S
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):90-94. PubMed ID: 33560076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19.
    Taufiq H; Shaik Fakiruddin K; Muzaffar U; Lim MN; Rusli S; Kamaluddin NR; Esa E; Abdullah S
    Ther Adv Respir Dis; 2023; 17():17534666231158276. PubMed ID: 37128999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.
    Yin F; Battiwalla M; Ito S; Feng X; Chinian F; Melenhorst JJ; Koklanaris E; Sabatino M; Stroncek D; Samsel L; Klotz J; Hensel NF; Robey PG; Barrett AJ
    Stem Cells; 2014 May; 32(5):1278-88. PubMed ID: 24452962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
    De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.
    Monsel A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Nguekap Tchoumba O; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Malard-Castagnet S; Burrel S; Rosenzwajg M; Tchitchek N; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Ropers J; Menasché P; Larghero J;
    Crit Care; 2022 Feb; 26(1):48. PubMed ID: 35189925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical application of mesenchymal stem cells for hematological diseases].
    Taketani T
    Rinsho Ketsueki; 2018; 59(10):2362-2372. PubMed ID: 30305547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
    Lanzoni G; Linetsky E; Correa D; Messinger Cayetano S; Alvarez RA; Kouroupis D; Alvarez Gil A; Poggioli R; Ruiz P; Marttos AC; Hirani K; Bell CA; Kusack H; Rafkin L; Baidal D; Pastewski A; Gawri K; Leñero C; Mantero AMA; Metalonis SW; Wang X; Roque L; Masters B; Kenyon NS; Ginzburg E; Xu X; Tan J; Caplan AI; Glassberg MK; Alejandro R; Ricordi C
    Stem Cells Transl Med; 2021 May; 10(5):660-673. PubMed ID: 33400390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis.
    Li R; Tu J; Zhao J; Pan H; Fang L; Shi J
    Stem Cell Res Ther; 2021 Feb; 12(1):106. PubMed ID: 33541414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease.
    Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringdén O
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1965-1969. PubMed ID: 31173898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highlighting the interaction between immunomodulatory properties of mesenchymal stem cells and signaling pathways contribute to Graft Versus Host Disease management.
    Mirfakhraie R; Ardakani MT; Hajifathali A; Karami S; Moshari MR; Hassani M; Firouz SM; Roshandel E
    Transpl Immunol; 2022 Apr; 71():101524. PubMed ID: 34990789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.
    Min CK; Kim BG; Park G; Cho B; Oh IH
    Bone Marrow Transplant; 2007 May; 39(10):637-45. PubMed ID: 17369865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.
    Stenger EO; Krishnamurti L; Galipeau J
    BMC Immunol; 2015 Dec; 16():74. PubMed ID: 26674007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
    Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.
    Bernardo ME; Locatelli F
    Methods Mol Biol; 2016; 1416():3-20. PubMed ID: 27236663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease.
    Kelly K; Rasko JEJ
    Front Immunol; 2021; 12():761616. PubMed ID: 34764962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft
    Chinnadurai R; Bates PD; Kunugi KA; Nickel KP; DeWerd LA; Capitini CM; Galipeau J; Kimple RJ
    Front Immunol; 2021; 12():708950. PubMed ID: 34386012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
    Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
    J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantation.
    Goto T; Murata M; Nishida T; Terakura S; Kamoshita S; Ishikawa Y; Ushijima Y; Adachi Y; Suzuki S; Kato K; Hirakawa A; Nishiwaki S; Nishio N; Takahashi Y; Kodera Y; Matsushita T; Kiyoi H
    Stem Cells Transl Med; 2021 Apr; 10(4):542-553. PubMed ID: 33314650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.